510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1144-2019Class II

Brilliance iCT, 728306

Philips North America LLC / initiated 2018-07-03 / Terminated / root cause: design

Philips Medical Systems (Cleveland) Inc began a recall of Brilliance iCT, 728306 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional images of the body by computer reconstruction of... on . FDA classified it as Class II and gives the reason as "Philips has identified that the compensator within the X-ray tube collimator may fail, resulting in ring or smudge artifacts on images. The firm has identified systems that may be at risk for this failure due to the...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1144-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips North America LLC
Product
Brilliance iCT, 728306 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional images of the body by computer reconstruction of X-ray transmission data taken at different angles and planes. This device may include signal analysis and display equipment, patient and equipment supports, components and accessories
Product code
JAK System, X-Ray, Tomography, Computed
Reason for recall
Philips has identified that the compensator within the X-ray tube collimator may fail, resulting in ring or smudge artifacts on images. The firm has identified systems that may be at risk for this failure due to the collimator compensator being past its lifetime expected usage.
Root cause tag
design
FDA root cause
Device Design
Action
On June 29. 2018, the firm sent Customer Information Letters to affected customers. The letter informed customers that Philips has identified that the compensator within the X-ray tube collimator may fail, resulting in ring or smudge artifacts on images. Customers were advised to review the user documentation provided with your system related to Quality Assurance checks. If artifacts are detected during review of the images produced by these checks, and are not removed with the recommended steps identified within your user documentation, please contact your service representative before resuming clinical use.
Quantity in commerce
2
Distribution
Distributed only to China and UK.
Product codes and lots
85028   100094

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1144-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1142-2019Class IITerminatedVoluntary: Firm initiated
Z-1143-2019Class IITerminatedVoluntary: Firm initiated
Z-1144-2019Class IITerminatedVoluntary: Firm initiated